# DEVELOPMENT_ROADMAP.md


## Project: OmniLatent

**Version:** 1.0  
**Status:** Active Development

---

# Vision

OmniLatent is envisioned as a next-generation scientific software framework for multimodal biomedical representation learning.

Rather than serving as a single deep learning model, OmniLatent is designed to become a reusable computational infrastructure for discovering biologically meaningful patient representations from heterogeneous molecular and clinical data.

The long-term objective is to bridge modern representation learning with translational biomedical research by constructing latent representations that capture the underlying biological organization of human disease while remaining interpretable, transferable, and reproducible.

The framework ultimately aims to support:

- Multimodal patient representation learning
- Cancer subtype discovery
- Cross-cancer knowledge transfer
- Clinical outcome modeling
- Molecular phenotype characterization
- Reproducible computational oncology research

Every software component is designed with long-term scientific usability rather than short-term experimental convenience in mind.

---

# Scientific Philosophy

OmniLatent follows a framework-oriented philosophy rather than a model-oriented implementation.

The central hypothesis is that patient embeddings should represent a reusable biological abstraction instead of being optimized solely for one downstream predictive task.

Consequently, representation learning becomes the primary objective, while downstream analyses—including clustering, visualization, survival modeling, subtype discovery, and biomarker identification—are treated as independent consumers of the learned latent space.

This philosophy allows the framework to evolve without changing its scientific foundation.

---

# Engineering Philosophy

The software architecture follows modern scientific software engineering principles.

Development is guided by the philosophy that research software should remain understandable, reproducible, extensible, and maintainable throughout the lifetime of the project.

The architecture therefore emphasizes:

- Separation of Concerns
- Modular software components
- Configuration-driven experimentation
- Reusable pipelines
- Independent evaluation modules
- Minimal coupling between subsystems

Production-quality source code is intentionally separated from exploratory analyses to ensure long-term maintainability.

---

# Core Design Principles

The following principles guide every architectural and implementation decision.

## Scientific First

Scientific validity always takes precedence over implementation complexity or computational optimization.

Every algorithmic choice must support a clearly defined biological question.

---

## Reproducibility

Every computational experiment should be reproducible from configuration files, software version, random seed, and stored outputs.

Experimental reproducibility is treated as a first-class design objective.

---

## Modularity

Individual software modules should remain replaceable without requiring modifications to unrelated components.

New datasets, neural architectures, preprocessing pipelines, and evaluation methods should integrate with minimal changes to the existing framework.

---

## Extensibility

The framework is intentionally designed to accommodate future representation learning paradigms including:

- Variational Autoencoders
- Contrastive Learning
- Graph Neural Networks
- Foundation Models
- Self-Supervised Learning
- Additional biomedical modalities

without requiring major architectural redesign.

---

## Scientific Transparency

Every intermediate computational artifact—including processed datasets, learned embeddings, evaluation metrics, figures, and trained models—should be explicitly generated, stored, and documented.

The framework favors transparent research workflows over hidden automation.

---

## Long-Term Maintainability

OmniLatent is intended to evolve as a research platform rather than a collection of isolated experiments.

Implementation decisions therefore prioritize readability, documentation quality, software organization, and future maintainability over short-term coding convenience.
---

# Development Phases

OmniLatent follows an incremental research and engineering strategy.

Each phase represents a reproducible milestone that produces independently verifiable scientific outputs before introducing additional architectural complexity.

The roadmap intentionally prioritizes correctness, reproducibility, and biological interpretability before large-scale model sophistication.

---

# Phase 0 — Project Foundation ✅

## Objective

Establish the scientific, computational, and software engineering foundations required for a long-term biomedical representation learning framework.

## Completed Activities

- Defined research objectives and scientific scope.
- Designed the software architecture.
- Organized repository structure.
- Established coding conventions.
- Implemented reproducible project configuration.
- Prepared software documentation.
- Established version control workflow.
- Defined experimental organization strategy.

## Deliverables

- Modular repository structure
- Software architecture specification
- Development roadmap
- Configuration system
- Reproducible project foundation

---

# Phase 1 — Data Acquisition 🟡

## Objective

Collect, validate, and organize high-quality multimodal biomedical datasets suitable for patient representation learning.

## Planned Tasks

### Molecular Data

- TCGA-BRCA RNA-seq
- Somatic mutation profiles
- Copy number variation (future)
- DNA methylation (future)

### Clinical Data

- Demographic variables
- Pathological staging
- Molecular subtype annotations
- Survival outcomes
- Treatment information (when available)

### Data Validation

- Harmonize patient identifiers.
- Validate sample consistency.
- Detect duplicated samples.
- Verify modality correspondence.
- Generate metadata summaries.

## Deliverable

A validated multimodal biomedical dataset with unified patient indexing.

---

# Phase 2 — Data Processing & Feature Engineering ⚪

## Objective

Construct standardized machine-learning representations while preserving biological information.

## Planned Tasks

### RNA Processing

- Log-normalization
- Gene filtering
- Feature quality control
- Variance assessment

### Clinical Processing

- Missing value handling
- Variable encoding
- Feature normalization
- Consistency verification

### Mutation Processing

- Binary mutation matrix generation
- Sparse feature representation
- Gene selection

### Dataset Integration

- Cross-modality alignment
- Patient matching
- Feature validation
- Dataset versioning

## Deliverable

A reproducible multimodal dataset suitable for representation learning experiments.

---

# Phase 3 — Baseline Representation Learning ⚪

## Objective

Establish strong computational baselines for quantitative comparison with future OmniLatent architectures.

## Planned Baselines

### Classical Methods

- Principal Component Analysis (PCA)
- Independent Component Analysis (future)

### Neural Baselines

- RNA AutoEncoder
- Variational AutoEncoder (future)

### Biological Factor Models

- MOFA+
- Additional published latent factor methods

## Evaluation

Each baseline will be evaluated using:

- Reconstruction quality
- Latent space visualization
- Clustering performance
- Embedding stability
- Computational efficiency

## Deliverable

A comprehensive baseline benchmark serving as the reference point for all future OmniLatent developments.

---

# Phase 4 — OmniLatent v1: Multimodal Representation Learning ⚪

## Objective

Develop the first complete version of OmniLatent capable of learning unified patient-level latent representations from heterogeneous biomedical modalities.

The representation learning module constitutes the scientific core of the framework and is intentionally designed to remain independent from downstream analysis components.

## Planned Architecture

```
                RNA Encoder
                     │
Clinical Encoder ────┼────► Shared Patient Latent Space
                     │
 Mutation Encoder ───┘
                     │
                     ▼
        Modality-specific Decoders
```

The shared latent representation becomes the primary computational output of the framework.

All downstream analyses operate exclusively on these learned patient embeddings.

---

## Planned Components

### Representation Learning

- RNA encoder
- Clinical encoder
- Mutation encoder
- Shared latent representation
- Modality-specific decoders

### Optimization

- Reconstruction objectives
- Latent regularization
- Representation consistency
- Stable optimization pipeline

### Infrastructure

- Checkpoint management
- Automatic configuration tracking
- Reproducible experiment logging
- Independent output directories

---

## Deliverable

A complete multimodal representation learning framework capable of generating biologically meaningful patient embeddings.

---

# Phase 5 — Biological and Computational Evaluation ⚪

## Objective

Quantitatively and biologically assess the quality of learned patient representations.

The evaluation framework is designed to measure both computational performance and biological relevance.

---

## Representation Quality

- Reconstruction error
- Latent space compactness
- Representation stability
- Embedding consistency

---

## Visualization

- PCA
- UMAP
- Cluster visualization
- Latent space exploration

---

## Unsupervised Analysis

- Clustering performance
- Cluster stability
- Internal validation metrics
- Representation separability

---

## Biological Evaluation

- Molecular subtype association
- Clinical variable association
- Survival analysis
- Biological pathway interpretation
- Patient stratification

---

## Deliverable

A comprehensive evaluation framework capable of measuring scientific usefulness rather than only numerical performance.

---

# Phase 6 — Cross-Cancer Generalization ⚪

## Objective

Evaluate whether learned representations capture transferable biological structure rather than cancer-specific statistical patterns.

---

## Planned Experiments

Training Cohort

- TCGA-BRCA

Transfer Cohorts

- TCGA-LUAD
- TCGA-KIRC

Evaluation Strategy

- Freeze learned encoder
- Generate embeddings
- Compare latent organization
- Compare clustering quality
- Benchmark against baseline methods

---

## Deliverable

A quantitative benchmark measuring cross-cancer transferability of learned representations.

---

# Phase 7 — Robustness and Ablation Studies ⚪

## Objective

Evaluate the robustness of learned representations under realistic biomedical data imperfections.

---

## Planned Experiments

### Missing Modality Analysis

- Missing RNA
- Missing clinical variables
- Missing mutation profiles

### Noise Robustness

- Expression perturbation
- Feature corruption
- Random masking

### Ablation Studies

- Remove modality-specific encoders
- Remove latent regularization
- Compare architecture variants

---

## Deliverable

A systematic robustness assessment of the OmniLatent framework.

---

# Phase 8 — Scientific Dissemination ⚪

## Objective

Transform the developed framework into a fully reproducible scientific research package suitable for publication.

---

## Planned Outputs

- Methods documentation
- Experimental protocol
- Quantitative results
- Publication-quality figures
- Supplementary analyses
- Open-source software release
- Research manuscript

---

## Deliverable

A publication-ready computational framework accompanied by complete scientific documentation suitable for peer-reviewed dissemination.

ب---

# Expected Outputs

Upon completion, OmniLatent is expected to provide a comprehensive scientific software ecosystem rather than a standalone deep learning model.

The framework will generate both computational artifacts and scientifically reusable resources.

---

## Software Outputs

- Modular biomedical representation learning framework
- Reproducible training pipelines
- Configuration-driven experimentation
- Independent evaluation modules
- Publication-quality visualization tools
- Extensible software architecture
- Comprehensive project documentation

---

## Scientific Outputs

- Patient-level latent representations
- Multimodal embedding datasets
- Cross-cancer representation benchmarks
- Biological clustering analyses
- Survival analysis pipelines
- Molecular subtype characterization
- Comparative baseline evaluations

---

## Reproducibility Outputs

Every completed experiment should automatically preserve:

- Experiment configuration
- Software version
- Random seed
- Model checkpoints
- Learned embeddings
- Evaluation metrics
- Figures
- Execution logs

Experimental outputs should remain immutable and independently reproducible.

---

# Long-Term Research Vision

OmniLatent is intended to evolve beyond a cancer-specific representation learning framework.

The long-term objective is to establish a general computational platform capable of integrating heterogeneous biomedical information across multiple diseases and molecular modalities.

Future versions are expected to support:

- Pan-cancer representation learning
- Multi-omics integration
- Transfer learning across diseases
- Foundation-model-inspired biomedical representations
- Clinical decision support research
- Precision medicine applications

The software architecture is intentionally designed to accommodate these future developments without requiring substantial structural redesign.

---

# Future Architectural Extensions

Potential future research directions include:

### Representation Learning

- Variational AutoEncoders (VAE)
- Contrastive Representation Learning
- Masked Representation Learning
- Self-Supervised Learning
- Diffusion-based Representation Learning

---

### Neural Architectures

- Graph Neural Networks
- Graph Attention Networks
- Transformer-based Encoders
- Multimodal Attention Networks
- Mixture-of-Experts Architectures

---

### Biomedical Modalities

- DNA Methylation
- Copy Number Variation
- Proteomics
- Histopathology Images
- Radiology Imaging
- Single-cell Transcriptomics
- Spatial Transcriptomics

---

### Downstream Biomedical Applications

- Survival Prediction
- Drug Response Modeling
- Biomarker Discovery
- Disease Subtyping
- Patient Similarity Networks
- Clinical Outcome Prediction

---

# Software Sustainability

OmniLatent is developed as an open scientific framework.

Future development prioritizes:

- clean software engineering,
- reproducible computational science,
- transparent experimentation,
- modular implementation,
- long-term maintainability,
- community-driven extensibility.

The project is intended to remain understandable and reusable beyond the lifetime of any single research study.

---

# Guiding Principle

> **Build a reusable scientific framework rather than a task-specific deep learning model.**

Every architectural decision should strengthen one or more of the following principles:

- Scientific reproducibility
- Biological interpretability
- Software quality
- Modular design
- Engineering simplicity
- Long-term maintainability
- Research impact

The ultimate success of OmniLatent will not be measured solely by predictive performance, but by its ability to provide reliable, interpretable, and transferable biomedical representations that enable future scientific discovery.

